US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Spdr S&P Biotech Etf

156.82

-2.5600-1.61%

Pre-market: 157.700.8800+0.56%06:21 EDT

Volume:9.71M

Turnover:1.52B

Market Cap:10.98B

PE:8.60

High:158.72

Open:157.59

Low:155.82

Close:159.38

52wk High:169.89

52wk Low:92.64

Shares:70.00M

Float Shares:70.00M

Volume Ratio:1.52

T/O Rate:13.87%

Dividend:0.56

Dividend Rate:0.36%

EPS(TTM):18.23

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Adicet Bio (ACET) and TG Therapeutics (TGTX)

Elevance update guidelines cover Freenome CRC test, says Guggenheim

Healthcare Realty Trust is Maintained at Equal-Weight by Wells Fargo

第二批次民营经济促进法执行示范案件公布

BioMarin Completes Acquisition of Dutch Biotech Alesta Therapeutics

Sector Update: Healthcare Stocks Mixed Premarket Tuesday

MT Newswires Live

Zhaoxian County's Biopharma Sector: Innovation-Driven Momentum in the New Five-Year Plan Era

Warning Signs; Buying Energy and Health Care; Still Cautious on QQQ and Now Also IWM

ResMed completes divestment of MatrixCare to Frazier Healthcare Partners

Kaisa Health Shareholders Approve Rebranding to Qinghai Biotech Pharmaceutical Group

Liquidia Corporation to Participate in Wells Fargo Annual Healthcare Conference

Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), Teladoc (TDOC) and Protagonist Therapeutics (PTGX)

Akebia Therapeutics to Conduct Investor Meetings at the 2026 Wells Fargo Healthcare Conference in Boston

Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference

Metagenomi Therapeutics, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference

Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference

Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Tenax Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference

Analysts Have Conflicting Sentiments on These Healthcare Companies: PROCEPT BioRobotics (PRCT), Invivyd (IVVD) and Alpha Tau (DRTS)

Alliance Healthcare Wins ALPS Tender for Mobile Inpatient Home Care Services

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/XBI/news?page=15"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"Spdr S&P Biotech Etf","latestPrice":156.82,"timestamp":1789070400000,"preClose":159.38,"halted":0,"volume":9708772,"hourTrading":{"tag":"盘前","latestPrice":157.7,"preClose":156.82,"latestTime":"06:21 EDT","volume":3691,"amount":581906.0813999999,"timestamp":1789122090532,"change":0.88,"changeRate":0.005612,"amplitude":0.006632},"delay":0,"changeRate":-0.016062241184590303,"floatShares":70000000,"shares":70000000,"eps":18.23,"marketStatus":"Pre-Mkt","change":-2.56,"latestTime":"09-11 06:22:33 EDT","open":157.59,"high":158.72,"low":155.82,"amount":1524788759.19668,"amplitude":0.018196,"askPrice":158,"askSize":200,"bidPrice":157.22,"bidSize":100,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789133400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":156.82,"sharesOutstanding":63325000,"nav":159.388213,"aum":10738780848.695,"dividendRate":0.0036,"bidAskSpread":0.000341,"preHourTrading":{"tag":"盘前","latestPrice":157.7,"preClose":156.82,"latestTime":"06:21 EDT","volume":3691,"amount":581906.0813999999,"timestamp":1789122090532,"change":0.88,"changeRate":0.005612,"amplitude":0.006632},"postHourTrading":{"tag":"盘后","latestPrice":156.6,"preClose":156.82,"latestTime":"19:58 EDT","volume":83781,"amount":13132833.9652,"timestamp":1789084712330,"change":-0.22,"changeRate":-0.001403,"amplitude":0.003061},"volumeRatio":1.5231930692292028,"impliedVol":0.3067,"impliedVolPercentile":0.456},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":70000000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.5231930692292028,"shares":70000000,"dividePrice":0.5646,"high":158.72,"amplitude":0.018196,"preClose":159.38,"low":155.82,"week52Low":92.64,"pbRate":"--","week52High":169.89,"institutionHeld":0.8511,"latestPrice":156.82,"committee":-0.333333,"eps":18.23,"divideRate":0.0036,"volume":9708772,"delay":0,"ttmEps":18.23,"open":157.59,"prevYearClose":121.93,"prevWeekClose":163.81,"prevMonthClose":162.5,"prevQuarterClose":158.25,"fiveDayClose":165.37,"twentyDayClose":159.39,"sixtyDayClose":136.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:15,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664486867","title":"Analysts Offer Insights on Healthcare Companies: Adicet Bio (ACET) and TG Therapeutics (TGTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664486867","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664486867?lang=en_us&edition=fundamental","pubTime":"2026-09-02 00:00","pubTimestamp":1788278431,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Adicet Bio (ACET) and TG Therapeutics (TGTX) with bu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-adicet-bio-acet-and-tg-therapeutics-tgtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-adicet-bio-acet-and-tg-therapeutics-tgtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","HCSG","BK4139","LU0128526141.USD","BK4585","ACET","BK4137","TGTX","LABU","BK4581","BK4588","XLV","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664685006","title":"Elevance update guidelines cover Freenome CRC test, says Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2664685006","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664685006?lang=en_us&edition=fundamental","pubTime":"2026-09-01 23:55","pubTimestamp":1788278138,"startTime":"0","endTime":"0","summary":"Guggenheim noted that Elevance Health’s (ELV) Carelon Healthcare Services unit updated its clinical guidelines for average-risk colorectal cancer s...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/elevance-update-guidelines-cover-freenome-crc-test-says-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/elevance-update-guidelines-cover-freenome-crc-test-says-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2430703095.HKD","LU0211331839.USD","LU0058720904.USD","LU2430703251.USD","LU0985489474.SGD","BK4588","LU1506573853.SGD","ELV","LU1720051017.SGD","LU0980610538.SGD","LU2237957811.SGD","LU1057294990.SGD","LU0266013472.USD","LU1670628061.USD","LU2357305700.SGD","LU0433182093.SGD","LU0314104364.USD","LU0314106906.USD","LU1201861249.SGD","LU0070302665.USD","LU0130517989.USD","LU0122379950.USD","LU1983299246.USD","LU0068578508.USD","LU0251142724.SGD","LU0640476718.USD","BK4213","LU0957791311.USD","LU0251131958.USD","LU0266512127.USD","LU0170899867.USD","LU1489326972.SGD","LU2237957902.USD","SG9999001077.SGD","LU0878866978.SGD","LU1023059063.AUD","BK4581","LU0048573561.USD","LU0061474960.USD","LU1815333072.USD","LU0882574055.USD","LU2244417387.USD","XLV","LABU","LU0456854461.SGD","SG9999004303.SGD","IHF","XBI","CRC","LU0320765489.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664385047","title":"Healthcare Realty Trust is Maintained at Equal-Weight by Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2664385047","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664385047?lang=en_us&edition=fundamental","pubTime":"2026-09-01 23:43","pubTimestamp":1788277380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HR/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1894683348.USD","LU0742534661.SGD","LU0048573561.USD","LU1035773651.USD","LU0128525689.USD","LU0175139822.USD","LU1267930227.SGD","LU2361044865.SGD","BK4203","LU1074936037.SGD","LU0942090050.USD","LU0072461881.USD","LU0256863811.USD","LU0162691827.USD","LU2236285917.USD","LU2361045086.USD","HR","LU0208291251.USD","LU0683600562.USD","IYF","LU1506573853.SGD","LU0708994859.HKD","HCSG","PGF","LU1267930573.SGD","LU0648001328.SGD","LU0980610538.SGD","LU0310799852.SGD","LABU","LU0868494617.USD","XBI","TFNS","BK4582","LU0029864427.USD","IE00B19Z3B42.SGD","FTXO","LU1069347547.HKD","XLV","LU0310800379.SGD","LU0128525929.USD","LU0070302665.USD","LU1267930490.SGD","LU0417517546.SGD","SRET","LU0868494708.USD","BK4585","LU0211328371.USD","LU0154236417.USD","KBWB","LU0640476718.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181370573","title":"第二批次民营经济促进法执行示范案件公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1181370573","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181370573?lang=en_us&edition=fundamental","pubTime":"2026-09-01 22:42","pubTimestamp":1788273742,"startTime":"0","endTime":"0","summary":"法治环境构成最优营商环境，而具体案例则是法律得以生动落实的衡量标准。在《中华人民共和国民营经济促进法》施行满一周年之际，国家发展改革委与最高人民法院联合发布了第二批贯彻实施该法律的典型案例，这些案例紧密围绕民企纾困解难、权益维护、公平市场竞争以及涉外争议解决四大重点领域，通过鲜活的司法裁判实践，切实打通了法律条文落地的“最后一公里”。从即日起，昆明市工商业联合会官方公众号将逐篇转载这些典型案例，旨...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","XBI","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664285768","title":"BioMarin Completes Acquisition of Dutch Biotech Alesta Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2664285768","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664285768?lang=en_us&edition=fundamental","pubTime":"2026-09-01 22:26","pubTimestamp":1788272819,"startTime":"0","endTime":"0","summary":"BioMarin Pharmaceutical ( ($BMRN) ) just unveiled an announcement. BioMarin Pharmaceutical Inc. has completed the acquisition of Dutch biotech comp...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biomarin-completes-acquisition-of-dutch-biotech-alesta-therapeutics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biomarin-completes-acquisition-of-dutch-biotech-alesta-therapeutics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NVIB","XBI","BK4539","BK4585","LENZ","XBIX","BK4007","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664285481","title":"Sector Update: Healthcare Stocks Mixed Premarket Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2664285481","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664285481?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:17","pubTimestamp":1788268638,"startTime":"0","endTime":"0","summary":"Healthcare stocks were mixed premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) 1% higher and the iShares Biotechnology ETF (IBB) down 0.5%Novartis (NVS) shares were up ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B2B36J28.USD","IE00B42XCP33.USD","LU2468319806.SGD","MEDX","LU0106261372.USD","HCSG","LU1506573853.SGD","IE00B3PB1722.GBP","IE00BGHQF631.EUR","IE0009355771.USD","LU1244550494.USD","BK4532","LU0211326755.USD","LU1116320901.HKD","BK4588","LABU","LU1244550221.USD","LU0496365809.HKD","LU0432979614.USD","IE000M9KFDE8.USD","IE00B4R5TH58.HKD","IE00BFXG1179.USD","LU0070302665.USD","IE00BDGV0183.EUR","LU2271345857.HKD","NVS","LU1244550577.SGD","LU1983299246.USD","LU2023251221.USD","IE00BJT1NW94.SGD","MDT","LU1989771016.USD","LU1989764664.SGD","LU0211326839.USD","LU2112291526.USD","LU0320765489.SGD","IBB","LU1061106388.HKD","LU2089284900.SGD","XBI","XLV","LU0314106906.USD","LU1023059063.AUD","LU0211331839.USD","IE0002141913.USD","LU2111349929.HKD","LU0158827781.USD","MMED","PPH","LU0072461881.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116450140","title":"Zhaoxian County's Biopharma Sector: Innovation-Driven Momentum in the New Five-Year Plan Era","url":"https://stock-news.laohu8.com/highlight/detail?id=1116450140","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116450140?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:11","pubTimestamp":1788268282,"startTime":"0","endTime":"0","summary":"Innovation serves as the primary engine for high-quality industrial development. As the opening year of the 15th Five-Year Plan begins, Zhaoxian County has zeroed in on building a ten-billion-yuan...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161726","BK4585","BK4581","399441","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664861272","title":"Warning Signs; Buying Energy and Health Care; Still Cautious on QQQ and Now Also IWM","url":"https://stock-news.laohu8.com/highlight/detail?id=2664861272","media":"Smartkarma","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664861272?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:48","pubTimestamp":1788266894,"startTime":"0","endTime":"0","summary":"utm_source=tiger_community","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.smartkarma.com/home/private-investor-solutions/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TQQQ","NOCT","URTY","BK4535","BK4534","AVUV","PSQ","SOXL","XLU","RSSL","IWF","BK4588","BK4561","MNQmain","RSP","TWM","SOXX","QDEC","BK4570","VTWO","SRTY","GPIQ","QID","QLD","RYLD","IWN","XBI","BK4593","NJAN","RWM","XLV","UWM","QQQM","SQQQ","BK4550","TQQY","SOXS","TNA","TECL","LABU","TZA","NDX","NAPR","QMAR","BK4581","QQQ","VB","IWMI","XLE","IWM","USSX","NJUL","BK4585","QQQX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664851950","title":"ResMed completes divestment of MatrixCare to Frazier Healthcare Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2664851950","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664851950?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:45","pubTimestamp":1788266735,"startTime":"0","endTime":"0","summary":"Resmed (RMD) announced the closing of its sale of MatrixCare to Frazier Healthcare Partners, a private equity firm focused on the healthcare indust...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/resmed-completes-divestment-of-matrixcare-to-frazier-healthcare-partners-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/resmed-completes-divestment-of-matrixcare-to-frazier-healthcare-partners-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0170899867.USD","LRCY","BK4504","XBI","BK4567","LGHT","CGCV","BK4588","NOBL","LU0128526141.USD","BK4581","RMD","BK4550","LU0029874061.USD","AAUM","PEVC","LU2177674079.SGD","TCAF","LABU","VHT","REDS","BK4137","BK4548","IXJ","RSBA","LU2008162690.USD","IE00B5TLWC47.USD","BK4082","HCSG","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664859710","title":"Kaisa Health Shareholders Approve Rebranding to Qinghai Biotech Pharmaceutical Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2664859710","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664859710?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:38","pubTimestamp":1788266298,"startTime":"0","endTime":"0","summary":"An update from Kaisa Health Group Holdings Limited ( ($HK:0876) ) is now available. Shareholders of Kaisa Health Group Holdings Limited have approv...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kaisa-health-shareholders-approve-rebranding-to-qinghai-biotech-pharmaceutical-group?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kaisa-health-shareholders-approve-rebranding-to-qinghai-biotech-pharmaceutical-group?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","XBI","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664851217","title":"Liquidia Corporation to Participate in Wells Fargo Annual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664851217","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664851217?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:30","pubTimestamp":1788265800,"startTime":"0","endTime":"0","summary":"MORRISVILLE, N.C., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced that Michael Kaseta, Chief Operating Officer and Chief Financial Officer, and Jason Adair, Ch","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354160/0/en/liquidia-corporation-to-participate-in-wells-fargo-annual-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000M9KFDE8.USD","BK4501","LU1267930490.SGD","LU0289960550.SGD","TFNS","BK4207","LU0708994859.HKD","LU1074936037.SGD","LU0868494617.USD","XLV","LU0072461881.USD","LU0211328371.USD","LU0320765489.SGD","LU0942090050.USD","LU0251142724.SGD","LU1814569148.SGD","LU1506573853.SGD","LU0310800965.SGD","BK4588","LU1267930573.SGD","WFC","LU0211327993.USD","KBWB","LU1267930227.SGD","LU0048573561.USD","LU0256863811.USD","LU1280957306.USD","LU0130517989.USD","LQDA","PGF","BK4559","XBI","IE00B19Z3581.USD","LU0128525689.USD","LU0477156953.USD","LU0175139822.USD","IYF","LU1894683348.USD","LU0980610538.SGD","LU2461242641.AUD","LABU","LU0070302665.USD","HCSG","IE0002270589.USD","FTXO","LU0052756011.USD","LU0310799852.SGD","LU0128525929.USD","LU0314106906.USD","LU0742534661.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664859516","title":"Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), Teladoc (TDOC) and Protagonist Therapeutics (PTGX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664859516","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664859516?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:10","pubTimestamp":1788264606,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Viridian Therapeutics (VRDN), Teladoc (TDOC) and P...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-viridian-therapeutics-vrdn-teladoc-tdoc-and-protagonist-therapeutics-ptgx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-viridian-therapeutics-vrdn-teladoc-tdoc-and-protagonist-therapeutics-ptgx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4504","BK4139","XLV","PTGX","BK4585","LABU","LU0029874061.USD","BK4167","BK4548","BK4567","LU1861559042.SGD","BK4534","LU1861558580.USD","LU0128526141.USD","BK4137","XBI","BK4588","HCSG","TDOC","VRDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664885625","title":"Akebia Therapeutics to Conduct Investor Meetings at the 2026 Wells Fargo Healthcare Conference in Boston","url":"https://stock-news.laohu8.com/highlight/detail?id=2664885625","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664885625?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:00","pubTimestamp":1788264000,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Sept.  01, 2026  -- Akebia Therapeutics, Inc. , a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, Chief Executive Officer and Erik Ostrowski, Chief Financial and Chief Business Officer, will participate in one-on-one meetings at the Wells Fargo Healthcare Conference, which will take place in Boston, September 8 – 10, 2026. During meetings, management will discuss its commercial products and its robust pipeline of clinical stage kidney disease programs. About Akebia TherapeuticsAkebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release. Akebia Therapeutics ContactMercedes Carrascomcarrasco@akebia.com","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354088/37519/en/akebia-therapeutics-to-conduct-investor-meetings-at-the-2026-wells-fargo-healthcare-conference-in-boston.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1280957306.USD","LU0029864427.USD","LU0980610538.SGD","LU1035773651.USD","LU0256863811.USD","LU0683600562.USD","LU1363072403.SGD","LU0742534661.SGD","IYF","HCSG","LU0267386448.USD","LU2361045086.USD","LU0128525689.USD","LU0971096721.USD","LU0310800379.SGD","AKBA","KBWB","LU0787776722.HKD","XLV","LU0868494708.USD","LU1668664300.SGD","BK4501","XBI","LU0208291251.USD","PGF","LU0149725797.USD","BK4588","LU1894683348.USD","LU0175139822.USD","FTXO","LU0130102774.USD","LU0251142724.SGD","LU0052756011.USD","LU0310800965.SGD","LU2361044865.SGD","LU1267930490.SGD","LU0048573561.USD","IE000M9KFDE8.USD","IE00B19Z3581.USD","LU0640476718.USD","IE00B19Z3B42.SGD","LU0310799852.SGD","LU1506573853.SGD","LABU","TFNS","LU0162691827.USD","LU1069347547.HKD","BK4139","LU0154236417.USD","LU0106831901.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664856297","title":"Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664856297","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664856297?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:00","pubTimestamp":1788264000,"startTime":"0","endTime":"0","summary":"BRIDGEWATER N.J., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Alan Bash, interim Chief Executi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354079/0/en/legend-biotech-to-participate-in-the-morgan-stanley-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEMS","FBT","BK4588","TBXU","BK4137","LU0128526141.USD","MEDI","CNCR","SYNB","XBI","XLV","BK4505","LEGN","GNOM","BK4139","IBB","LFSC","IBBQ","LABU","LU0029874061.USD","BK4585","BK4581","HCSG","CANC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664562148","title":"Metagenomi Therapeutics, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664562148","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664562148?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:00","pubTimestamp":1788264000,"startTime":"0","endTime":"0","summary":"EMERYVILLE, Calif., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Metagenomi Therapeutics, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary technologies to c","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354046/0/en/metagenomi-therapeutics-inc-to-present-at-the-wells-fargo-21st-annual-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","LU0256863811.USD","LU0310800965.SGD","LU0128525929.USD","FTXO","LU0971096721.USD","LU2236285917.USD","LU0208291251.USD","TFNS","IYF","LU0106831901.USD","LU0787776722.HKD","MGX","LU1363072403.SGD","LU0175139822.USD","IE000M9KFDE8.USD","LU1506573853.SGD","LU0029864427.USD","HCSG","LU0868494617.USD","LU1668664300.SGD","BK4559","XLV","LU0128525689.USD","LU0417517546.SGD","LU0477156953.USD","BK4539","LU0128526141.USD","LU0211328371.USD","LENZ","PGF","BK4007","LU2361044949.HKD","LU0130102774.USD","KBWB","LU0211327993.USD","LU0251142724.SGD","LU0314106906.USD","LU0149725797.USD","LU1267930490.SGD","LABU","LU0130517989.USD","LU0154236417.USD","LU2361044865.SGD","LU1074936037.SGD","BK4501","IE00B19Z3B42.SGD","LU0708994859.HKD","LU0072461881.USD","LU0048573561.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664485625","title":"Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664485625","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664485625?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:00","pubTimestamp":1788264000,"startTime":"0","endTime":"0","summary":"CORAL GABLES, Fla., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354047/0/en/relmada-therapeutics-to-participate-at-the-wells-fargo-21st-annual-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4582","LU0175139822.USD","LU0320765489.SGD","LU1035773651.USD","LU1267930573.SGD","BK4539","LU0128525929.USD","LU1280957306.USD","IE00B19Z3B42.SGD","LU0256863811.USD","LU0868494708.USD","LU2461242641.AUD","LU2361045086.USD","BK4588","LU0742534661.SGD","LU0477156953.USD","LU1668664300.SGD","BK4137","LU0128526141.USD","IYF","LU0029864427.USD","IE00B19Z3581.USD","FTXO","LU0128525689.USD","LU0310799852.SGD","LU0052756011.USD","IE00B7SZLL34.SGD","LU0640476718.USD","LU0942090050.USD","LU0648001328.SGD","XBI","LU0162691827.USD","TFNS","PGF","LU2361044949.HKD","XLV","LENZ","IE0002270589.USD","LU0072461881.USD","KBWB","LU0149725797.USD","LU1267930490.SGD","LU0211327993.USD","BK4139","LU0314106906.USD","LU1894683264.USD","LABU","LU0154236417.USD","HCSG","LU1069347547.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664868855","title":"Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664868855","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664868855?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:00","pubTimestamp":1788260400,"startTime":"0","endTime":"0","summary":"CAMBRIDGE, Mass., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Parabilis Medicines (Nasdaq: PBLS), a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with ser","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3353946/0/en/parabilis-medicines-to-participate-in-the-morgan-stanley-24th-annual-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACP","BK4581","XBI","LABU","BK4139","BK4137","COAL","BK4588","LU0128526141.USD","PBLS","XLV","BK4006","HCC","HCSG","BK4585","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664485589","title":"Tenax Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664485589","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664485589?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:00","pubTimestamp":1788260400,"startTime":"0","endTime":"0","summary":"CHAPEL HILL, N.C., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or “Tenax Therapeutics” or the “Company”) announced today that Chris Giordano, President & Chief","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3353934/12401/en/tenax-therapeutics-to-participate-in-the-2026-cantor-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","LU0128526141.USD","BK4585","BK4007","XBI","XLV","BK4539","BK4139","BK4581","HCSG","BK4137","LU0029874061.USD","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664685804","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: PROCEPT BioRobotics (PRCT), Invivyd (IVVD) and Alpha Tau (DRTS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664685804","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664685804?lang=en_us&edition=fundamental","pubTime":"2026-09-01 18:30","pubTimestamp":1788258644,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on PROCEPT BioRobotics (PRCT), Invivyd (IVVD) and Alp...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-procept-biorobotics-prct-invivyd-ivvd-and-alpha-tau-drts-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-procept-biorobotics-prct-invivyd-ivvd-and-alpha-tau-drts-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DRTS","BK4585","LU0128526141.USD","LU2324357040.USD","XBI","LU0029874061.USD","BK4539","PRCT","BK4139","IVVD","HCSG","XLV","BK4137","BK4082","BK4581","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664830282","title":"Alliance Healthcare Wins ALPS Tender for Mobile Inpatient Home Care Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2664830282","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664830282?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:48","pubTimestamp":1788256126,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Alliance Healthcare Group Ltd. ( ($SG:MIJ) ). Alliance Healthcare Group has secured a three-year tender from AL...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alliance-healthcare-wins-alps-tender-for-mobile-inpatient-home-care-services?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alliance-healthcare-wins-alps-tender-for-mobile-inpatient-home-care-services?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","SG","BK4585","XBI","HBCP","BK4195","XLV","BK4581","HCSG","BK4137","BK4209","LU0029874061.USD","BK4588","LABU","BK4211"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":19,"pageCount":15,"totalSize":371,"code":"91000000","status":"200"}]}}